Promise of multiphoton detection in discovery and diagnostic proteomics

Expert Review of Proteomics

Volumn 4, Issue 2, 2007, Pages 161-173

  Godovac Zimmermann, Jasminka ^a   Mulvey, Claire ^a   Konstantoulaki, Maria ^a   Sainsbury, Richard ^a   Brown, Larry R ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b OncoTraces Ltd   (United Kingdom)

Author keywords

Cancer; Immunoassay; Multiphoton detection; Protein isoform; Proteomics; Top down; Ultrasensitive

Indexed keywords

CELL PROTEIN; ISOPROTEIN; VASCULOTROPIN A;

ANGIOGENESIS; BREAST CANCER; CANCER DIAGNOSIS; CELL COUNT; DEVICE; DIAGNOSTIC PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; ISOTOPE LABELING; MITOGENESIS; MULTIPHOTON MICROSCOPY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEOMICS; REVIEW;

BLOOD PROTEINS; DIAGNOSTIC TECHNIQUES AND PROCEDURES; HUMANS; IODINE RADIOISOTOPES; METHODS; NEOPLASM PROTEINS; PHOTONS; PROTEINS; PROTEOMICS;

EUKARYOTA;

EID: 34247126011     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.4.2.161     Document Type: Review

References (28)

1. Domon B, Aebersold R. Mass spectrometry and protein analysis. Science 312, 212-217 (2006). • Review of recent advances in mass spectrometry.
2. Smith RD, Tang K, Shen Y. Ultra-sensitive and quantitative characterization of proteomes. Mol. Biosyst. 2, 221-230 (2006).
3. Mann M. Functional and quantitative proteomics using SILAC. Nat. Rev. Mol. Cell Biol. 7, 952-958 (2006).
4. Stannard C, Brown LR, Godovac-Zimmermann J. New paradigms in cellular function and the need for top-down proteomics analysis. Curr. Proteomics 1, 13-25 (2004).
5. Godovac-Zimmermann J, Kleiner O, Brown LR, Drukier AK. Perspectives in spicing up proteomics with splicing. Proteomics 5, 699-709 (2005). •• Describes the limits of applicability of the current proteomics concept and methodologies to higher eukaryotes.
6. Han X, Jin M, Breuker K, McLafferty FW. Extending top-down mass spectrometry to proteins with masses greater than 200 kilodaltons. Science 314, 109-112 (2006).
7. Boyne MT II, Pesavento JJ, Mizzen CA, Kelleher NL. Precise characterization of human histones in the H2A gene family by top down mass spectrometry. J. Proteome Res. 5, 248-253 (2006).
8. Zabrouskov V, Senko MW, Du Y, Leduc RD, Kelleher NL. New and automated MSn approaches for top-down identification of modified proteins. J. Am. Soc. Mass Spectrom. 16, 2027-2038 (2005).
9. Chizzonite R, Truitt T, Podlaski FJ et al. IL-12: monoclonal antibodies specific for the 40-kDa subunit block receptor binding and biologic activity on activated human lymphoblasts. J. Immunol. 147, 1548-1556 (1991).
10. Kleiner O, Price DA, Ossetrova N et al. Ultra-high sensitivity multi-photon detection imaging in proteomics analyses. Proteomics 5, 2322-2330 (2005). •• Describes multiphoton detection method in proteomics analysis.
11. Gasparini G. Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist 5, 37-44 (2000).
12. Lee S, Jilani SM, Nikolova GV, Carpizo D, Iruela-Arispe ML. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J. Cell Biol. 169, 681-691 (2005).
13. Bornes S, Boulard M, Hieblot C et al. Control of the vascular endothelial growth factor internal ribosome entry site (IRES) activity and translation initiation by alternatively spliced coding sequences. J. Biol. Chem. 279, 18717-18726 (2004).
14. Takahashi H, Shibuya M. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin. Sci. 109, 227-241 (2005).
15. Yu JL, Rak JW, Klement G, Kerbel RS. Vascular endothelial growth factor isoform expression as a determinant of blood vessel patterning in human melanoma xenografts. Cancer Res. 62, 1838-1846 (2002).
16. Lin HJ, Hsieh FC, Song H, Lin J. Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer. Br. J. Cancer 93, 1372-81 (2005).
17. Stambolic V, Woodgett JR. Functional distinctions of protein kinase B/Akt isoforms defined by their influence on cell migration.Trends Cell Biol. 16, 4661-4666 (2006).
18. Ghaemmaghami S, Huh W-K, Bower K et al. Global analysis of protein expression in yeast. Nature 425, 737-741 (2003).
19. Zhang HT, Scott PA, Morbidelli L et al. The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br. J. Cancer 83, 63-68 (2000).
20. Fenton BM, Paoni SF, Liu W, Cheng SY, Hu B, Ding I. Overexpression of VEGF121, but not VEGF165 or FGF-1, improves oxygenation in MCF-7 breast tumours. Br. J. Cancer 90, 430-435 (2004).
21. Yuan A, Yu CJ, Kuo SH et al. Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer. J. Clin. Oncol.19, 432-441 (2001).
22. Wingren C, Borrebaeck CA. Antibody microarrays: current status and key technological advances. Omics 10, 411-427 (2006).
23. Haab BB. Applications of antibody array platforms. Curr. Opin. Biotechnol. 17, 415-421 (2006).
24. Kung LA, Snyder M. Proteome chips for whole-organism assays. Nat. Rev. Mol. Cell Biol. 7, 617-622 (2006).
25. Kingsmore SF. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat. Rev. Drug Discov. 5, 310-320 (2006).
26. Drukier AK, Ossetrova N, Schors E et al. Ultra-sensitive immunoassays using multi-photon-detection in diagnostic proteomics of blood. J. Proteome Res. 4, 2375-237 (2005). • Describes the development of ultrasensitive immunoassay using multiphoton detection.
27. Drukier AK, Ossetrova N, Schors E et al. High-sensitivity blood-based detection of breast cancer by multi-photon-detection diagnostic proteomics. J. Proteome Res. 5, 1906-1915 (2006). •• Describes the development of ultrasensitive detection of breast cancer using multiphoton detection.
28. Drukier AK, Grigoriev I, Brown LR, Tomaszewski JE, Sainsbury R, Godovac-Zimmermann J. Looking for Thom's biomarkers with proteomics. J. Proteome Res. 5, 2046-2048 (2006).